These injections are given under the skin ... effect article about Xolair or refer to Xolair’s prescribing information. Xolair is also approved to treat other conditions. It’s important ...

The approved dose is 300 mg by subcutaneous injection every four weeks. "The EU approval of Xolair in CSU is truly exciting for patients with this chronic and debilitating skin disease," said ...

Participants in stage one were assigned to receive placebo or Xolair injections every two or four ... a GlobalData owned brand. The information on this site has been included in good faith for ...

Omalizumab is generally well tolerated in adults and children with allergic asthma. Adverse events most commonly observed are injection-site reaction, viral infection, upper-respiratory-tract ...

The FDA has approved a new prefilled syringe formulation for Roche’s asthma drug Xolair, as the Swiss company ... in the US and EU as a subcutaneous injection lasting a few minutes, instead ...